Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * be a male or female 18 years of age or older. * for females: be of non-childbearing potential or willing to use appropriate contraceptive measures for 30 days prior to vaccination through 6 months after completion of the vaccine series. * willingness to provide a signed, printed, and dated informed consent form. * able and willing to participate in all activities in the clinical trial. * participants with hiv, hbv, hcv should have a health record, determined to be stable for 6 months prior to the screening.

inclusion criteria: * be a male or female 18 years of age or older. * for females: be of non-childbearing potential or willing to use appropriate contraceptive measures for 30 days prior to vaccination through 6 months after completion of the vaccine series. * willingness to provide a signed, printed, and dated informed consent form. * able and willing to participate in all activities in the clinical trial. * participants with hiv, hbv, hcv should have a health record, determined to be stable for 6 months prior to the screening.

June 15, 2021, 12:32 a.m. usa

inclusion criteria: - be a male or female 18 years of age or older. - for females: be of non-childbearing potential or willing to use appropriate contraceptive measures for 30 days prior to vaccination through 6 months after completion of the vaccine series. - willingness to provide a signed, printed, and dated informed consent form. - able and willing to participate in all activities in the clinical trial. - participants with hiv, hbv, hcv should have a health record, determined to be stable for 6 months prior to the screening.

inclusion criteria: - be a male or female 18 years of age or older. - for females: be of non-childbearing potential or willing to use appropriate contraceptive measures for 30 days prior to vaccination through 6 months after completion of the vaccine series. - willingness to provide a signed, printed, and dated informed consent form. - able and willing to participate in all activities in the clinical trial. - participants with hiv, hbv, hcv should have a health record, determined to be stable for 6 months prior to the screening.